The evolution of bladder cancer treatment: improvements in clinical management, enhanced clinical outcomes, and targeting newly identified molecular alterations.
Bajorin
Dean F
DF
D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D006801:Humans; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000628:therapy*
D014408:Biomarkers, Tumor